Jafron Biomedical Co.,Ltd. engages in the research and development, production, and sale of blood purification products for hemadsorption field worldwide. The company offers therapies for kidney, liver, and critical diseases, as well as poisoning. It also provides HA series disposable hemoperfusion cartridge; BS series disposable plasma bilirubin perfusion adsorption column; blood purification machine; and other products, such as JM hemodialyzer, DNA230, disinfectant, hemodialysis concentrate, resin bandage, online hemodialysis B powder bag/bucket, PGA absorbable suture with needle, syringe and infusion pumps. The company was founded in 1989 and is based in Zhuhai, China.
Metrics to compare | 300529 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship300529PeersSector | |
|---|---|---|---|---|
P/E Ratio | 32.3x | 36.0x | −0.6x | |
PEG Ratio | −0.85 | −0.58 | 0.00 | |
Price/Book | 4.5x | 3.1x | 2.6x | |
Price / LTM Sales | 7.6x | 7.8x | 3.3x | |
Upside (Analyst Target) | 34.6% | 28.6% | 41.8% | |
Fair Value Upside | Unlock | 13.2% | 6.2% | Unlock |